Latham & Watkins represented Zentalis Pharmaceuticals in the transaction. Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological...
Pfizer’s $25 Million Equity Investment in Zentalis Pharmaceuticals
The Vita Coco Company’s $173 Million Initial Public Offering
Latham & Watkins represented The Vita Coco Company, Inc. in the offering. The Vita Coco Company, Inc., a leading platform of high-growth better-for-you brands formerly known as...
Rivian Automotive’s Initial Public Offering
Latham & Watkins advised Rivian Automotive, while Skadden, Arps, Slate, Meagher & Flom advised the underwriters in the Initial Public Offering. Rivian Automotive, Inc. has announced its...
Global-e Online’s $883 Million Shares Offering
Latham & Watkins advised Global-e Online on the deal, while Gornitzky represented the underwriters. Global-e Online Ltd. announced the pricing of its underwritten secondary offering by certain...
Driven Brands’ $407 Million Secondary Offering
Latham & Watkins represented the underwriters in the offering. Driven Brands Holdings Inc. has announced the pricing of the underwritten secondary public offering of 12 million...
Zentalis Pharmaceuticals’ $150.4 Million Common Stock Offering
Latham & Watkins LLP represented Zentalis Pharmaceuticals in the offering. Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting...
Global-e Online’s Initial Public Offering
Latham & Watkins advised Global-e Online on the deal. Global-e Online (Global-e), the world’s leading platform to enable and accelerate global, direct-to-consumer cross-border e-commerce, executed its...
Roivant Sciences Ltd.’s Merger with Montes Archimedes Acquisition Corp.
Conyers and Davis Polk & Wardwell is advising Roivant Sciences Ltd., in its business combination by merger of a subsidiary with Montes Archimedes Acquisition Corp. (MAAC)...
Outset Medical’s Primary and Upsized Secondary Public Offering
Latham & Watkins LLP represented the underwriters in the offering while Sidley Austin LLP advised Outset Medical, Inc. Outset Medical, Inc., a medical technology company pioneering...
Achilles Therapeutics’ $175.5 Million Initial Public Offering
Latham & Watkins LLP represented the underwriters in the offering while Goodwin Procter LLP advised Achilles Therapeutics plc. Achilles Therapeutics plc, a clinical-stage biopharmaceutical company developing...